Coronavirus bonds: China must be vigilant

Chinese regulators will have to strike a balance between supporting the use of the domestic bond market to help combat the deadly outbreak of the coronavirus, now officially known as Covid-19, and preventing the misuse of it.

  • By Addison Gong
  • 13 Feb 2020
Email a colleague
Request a PDF

As the Covid-19 outbreak persists in the mainland and elsewhere, China seems to be doing everything it can to stabilise the financial markets.

Led by the likes of People’s Bank of China, China Banking and Insurance Regulatory Commission and the Ministry of Finance, regulators at central and local government levels have rolled out more than 30 different supportive measures over the last two weeks.

They also made it easier for companies with funding needs to come to the bond market, setting up ‘green channels’ for fast-tracked issuance, extending deadlines for those temporarily not able to print, relaxing the restrictions on the use of bond proceeds and lowering the associated fees.

Chinese policy banks, hospital builders and pharmaceutical firms last week issued the first batch of bonds to help prevent and control the epidemic. While only China Development Bank’s Rmb13.5bn ($1.94bn) deal was clearly labelled a ‘Novel Coronavirus Prevention Bond’, all or at least part of the proceeds of every deal were intended to be used to fight for the same cause.

That trend is quickly catching on. By Thursday this week, more than 20 issuers had priced or will soon price deals relating to the coronavirus, with or without a clear label, according to public filings.

The range of issuer types has also expanded, now taking in airline companies, automobile manufacturers, food suppliers, local government financing vehicles and brokerages. But unlike those that came out earlier, most of the firms have now decided to label their offerings clearly as coronavirus-related.

The benefits of labelling their deals clearly are evident: more publicity, better investor participation, and lower funding cost.

Existing issuers have provided enough justifications in the bond prospectuses. But since issuance could potentially last for at least a couple of months, the market needs to be vigilant about any exploitation of these coronavirus bonds. In the midst of a tough funding environment for Chinese borrowers, there will no doubt be a temptation to exaggerate the relevance of the coronavirus to financing.

China’s three policy banks ─ Agricultural Development Bank of China, China Development Bank and Export-Import Bank of China ─ came out in size, but the majority of the deals so far have been much smaller. They have typically been issued by non-financial companies in China’s interbank market and regulated by the National Association of Financial Market Institutional Investors, or Nafmii.

Nafmii, however, requires only 10% of the proceeds from each bond to be related to the prevention and control of the outbreak for companies to put a clear coronavirus label on their deals. Issuers also do not need to add the label during the approval or registration process, but can tack it on just before the issuance stage.

While these relaxed requirements show support from Chinese regulators, a higher barrier for entry will help make sure that all companies that sell coronavirus bonds have a genuine need to do so, instead of having some issuers abuse the label in exchange for cheaper prices ─ or simply to be able to print a deal in the first place.

Introducing a step of pre-registration certification and an after-issuance verification process would also help avoid the misuse of the proceeds.

Companies should also be made aware of the consequences before they start taking advantage of the bond market. China has already said it will have zero tolerance on behaviour such as hiking up prices for food and medical supplies, including surgical and N95 masks, amid the outbreak.

When it comes to the financial markets, the regulator will need to pull off a balancing act between showing support and adopting a tougher stance. There is little margin for error as the country tries to restore market confidence. 

  • By Addison Gong
  • 13 Feb 2020

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 Bank of China (BOC) 18.86
2 Industrial and Commercial Bank of China (ICBC) 14.39
3 China Merchants Bank Co 14.21
4 China Merchants Securities Co 8.85
5 Agricultural Bank of China (ABC) 5.90

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 China International Capital Corp Ltd 4.57 23 12.79%
2 China Securities Co Ltd 3.53 7 9.87%
3 Morgan Stanley 3.39 11 9.47%
4 CITIC Securities 3.29 11 9.21%
5 Goldman Sachs 1.70 13 4.77%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $bn No of issues Share %
  • Last updated
  • Today
1 Citi 6.90 37 7.97%
2 HSBC 5.80 49 6.69%
3 UBS 4.41 27 5.09%
4 BofA Securities 4.13 14 4.76%
5 JPMorgan 4.04 26 4.67%

Asian polls & awards

  • GlobalCapital China 2019 awards winners: Part III

    In the final part of GlobalCapital China’s awards announcement, we discuss the key innovation of 2019, and reveal the individual that has made the greatest contribution to reforming and internationalising the Chinese onshore market.

  • GlobalCapital China 2019 awards winners: Part II

    In the second part of GlobalCapital China’s awards announcement, we reveal the winning banks across Panda bonds, G3 bonds and ABS, as well as the best bank for securities services and the most impressive law firm.

  • GlobalCapital Asia capital markets awards 2019: Investment banks

    In the fourth and final instalment of GlobalCapital Asia’s capital markets awards announcements, find out which firms have been named the Best Asian Investment Bank and the Best Investment Bank in the region for 2019.

  • GlobalCapital China announces 2019 awards winners: Part I

    GlobalCapital China, previously GlobalRMB, is pleased to announce the winners of its annual capital markets awards, honouring the banks, companies and individuals that have made the biggest contribution to bridging the gap between China’s markets and the rest of the world. In part one of the awards, we reveal the most impressive issuers in the FIG, corporate and SSA categories.

  • GlobalCapital Asia capital markets awards 2019: Bonds

    In part three of GlobalCapital Asia's awards results announcements, we reveal the winning bond deals across a variety of categories. In addition, we also name the Best G3 Bond House, Best High Yield Bond House and the winner of the Best House for SRI Financing.